Operationalizing Expanded Access in 2026: From Strategy to Scalable Execution
- Understanding how Expanded Access expectations have evolved following recent FDA guidance – and what this means for program design today
- Navigating the realities of implementing global EAPs across regions with differing regulatory frameworks and infrastructure
- Establishing clear ownership: which functions should lead, support, and govern Expanded Access programs as they scale